Executive Director/Vice President, Program Leadership New Somerville, Massachusetts, United States

Somerville, Massachusetts, United States You are interested in… Establishing vision and strategy to lead two Program teams developing genome editing therapies for rare diseases, from early development through to registration Providing strategic leadership and development acumen as part of the company's Leadership Team Promoting collaborative and socially intelligent team environments with effective communication Managing target product profiles, ensuring alignment across the enterprise Being accountable for the execution of integrated development plans to agreed scope, timelines, resources, & budget- collaborating and partnering with the appropriate leaders across the enterprise Leading communication on program development strategy at governance meetings, and driving optimization of programs decision-making, using Tessera’s internal decision-making framework Partnering with key internal stakeholders and Program Managers to ensure timelines, processes, plans and data are in place to enable investment decisions and prioritization across the enterprise portfolio Fostering a development culture of collaboration and innovation, focused on scientific excellence, data-driven arguments, and efficiency Maintaining clear internal communication on program status, priorities, risks, and needs as primary advocate for the programs (including with senior leadership) Monitoring and guiding the program budgets in collaboration with PM and Finance Minimum Requirements: An advanced degree in Life Sciences (PhD, MD, M.Sc., Pharm.D., or equivalent) 15+ years in the biopharmaceutical industry in leadership positions working on programs from preclinical development to commercialization Proven and respected leadership of cross-functional development teams in a matrixed environment, with an exceptional track record of delivering on business objectives and activity/milestones leading to filing and launching An in-depth understanding of how CMC, Nonclinical, Clinical/Medical, Regulatory and Quality disciplines need to partner to expedite development Strong know-how to quickly develop and maintain broad program knowledge (relevant platform, key data and precedents, patient population, market and policy environment, competitive development and global payer landscape, etc.) Proven ability to establish and maintain credible and trust-based relationships with external stakeholders (e.g., KOLs, patient advocacy groups, etc.) It’s a bonus if you’ve worked in a global environment or on innovative medicinal products for rare diseases About you: You are enthusiastic about Tessera's mission to bring potentially curative treatments to patients and the exciting work it will take to realize it with high efficiency You are a visionary leader with an entrepreneurial style who thrives in creating opportunities, solving problems and successfully driving complex projects and healthy and transparent decision making You have a strong scientific background to understand the details of Tessera’s novel genome editing approaches and are comfortable with limited precedents for development You have excellent communication skills (verbal, written, presentation) and the ability to communicate in an open, clear, complete, timely and consistent manner with all stakeholders and teams- at all levels You are comfortable influencing without direct authority You are a team player who partners and listens effectively, inviting response and discussion You favor collective achievement, team credit, and celebration- combined with an individual sense of responsibility and accountability for teamwork and product You are comfortable in a results-driven, highly accountable, and fast-paced environment where you can make a clear impact Tessera employees are creative and collaborative problem solvers. They have a strong sense of integrity and unwavering commitment to scientific excellence. Company Summary: Tessera Therapeutics is pioneering Gene Writing— a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. More about Tessera Therapeutics: Tessera is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, age, sex, national origin, disability status, marital status, genetics, protected veteran status, citizenship status, sexual orientation, gender identity or expression, or any other characteristic identified by federal, state, or local laws where we operate. Tessera provides reasonable accommodations to qualified applicants and employees with disabilities. #J-18808-Ljbffr